Literature DB >> 10836696

Functioning liver metastases on an I-131 whole-body scan: a case of malignant struma ovarii.

O Konez1, L G Hanelin, E L Jenison, M Goyal, W Randolph.   

Abstract

A 46-year-old women was examined for severe constipation. Pelvic examination revealed a large pelvic mass extending to the level of the umbilicus. Computed tomography showed a large multicystic, septated mass in the pelvis and a small amount of fluid in the cul de sac. In addition, multiple ill-defined, mixed-attenuation hepatic lesions were identified. A malignant ovarian neoplasm with liver metastases was considered, so the pelvic mass was resected. Interestingly, histopathologic analysis revealed malignant struma ovarii of the follicular type. Biopsy of the liver lesions confirmed metastatic disease with similar histopathologic findings. All thyroid laboratory values were in the normal range. The patient then had a total thyroidectomy to optimize thyroid ablation therapy with I-131. This revealed a small follicular adenoma but no evidence of cancer. An I-131 whole-body scan was performed and showed uptake in multiple functioning liver metastases.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10836696     DOI: 10.1097/00003072-200006000-00014

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  3 in total

1.  False-positive uptake on radioiodine whole-body scintigraphy: physiologic and pathologic variants unrelated to thyroid cancer.

Authors:  Jong-Ryool Oh; Byeong-Cheol Ahn
Journal:  Am J Nucl Med Mol Imaging       Date:  2012-07-10

2.  Malignant Struma Ovarii Τreated With Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC).

Authors:  Miklos Acs; Sebastian Häusler; Hamid-Reza Lighvani; Jozef Zustin; Pompiliu Piso
Journal:  In Vivo       Date:  2021 Nov-Dec       Impact factor: 2.155

3.  Extensive peritoneal implant metastases of malignant struma ovarii treated by thyroidectomy and 131I therapy: A case report.

Authors:  Mengxue Wu; Fengqiong Hu; Xing Huang; Zuwen Tan; Chengming Lei; Dong Duan
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.